温针灸为主治疗前列腺增生症疗效观察

笔者于1998年2月～1999年12月应用温针灸为主治疗前列腺增生症51例,效果理想.现报道如下. 1临床资料 1.1病例选择全部98例观察病例均来自男科门诊.按随机法分为治疗组和对照组.其中治疗组51例,年龄最小49岁,最大72岁,平均56.3岁;病程最短2年,最长5年,平均4.1年.对照组47例,年龄最小48岁,最大71岁,平均57.1岁;病程最短3年,最长7年,平均5.0年.两组具有可比性.     

X-linked hypophosphatemia: Normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia

Nephrocalcinosis (NC) detected by ultrasound is a recognized abnormality for some patients with X-linked hypophosphatemia (XLH) who received vitamin D₂ and inorganic phosphate therapy, but is commonly observed in XLH patients treated with 1,25-dihydroxyvitamin D₃ and inorganic phosphate supplementation. Nevertheless, long-term follow-up of kidney function in XLH patients with NC detected ultrasonographically has not been reported. We investigated two women with XLH, ages 31 (patient 1) and 39 (patient 2) years, each of whom had suffered at least one documented episode of vitamin D₂-induced hypercalcemia and renal azotemia during childhood. Patient 2 had also been treated with inorganic phosphate. No medications for XLH had been taken during adulthood. Renal ultrasonography at our institution demonstrated marked bilateral medullary NC in both women. No other explanation was found for their NC that apparently occurred several decades earlier from medical therapy for XLH. Detailed studies (including creatinine clearance, β₂-microglobulin excretion, and fasting urinary osmolality and acidification) revealed no impairment of kidney function in either patient. Our findings indicate that subradiographic medullary NC acquired during medical therapy for XLH may persist for decades, but with no adverse renal sequelae. Definitive (long-term) assessment of kidney function in the XLH population with NC, however, will be necessary to fully understand the risk of current medical treatment for this most common heritable form of rickets.     

Hepatic falciform artery

The hepatic falciform artery is an occasional terminal branch of the left or middle hepatic artery, and may provide an uncommon but important collateral route when the principal visceral arteries are occluded.     

小儿疳证源流考

疳作为一个病名，最早见于隋《诸病源候论》。首先将疳证作为儿科专有疾病者，为宋初《太平圣惠方》。本病分类最全面，收集方剂最丰富当推宋《幼幼新书》。南宋出版的《小儿卫生总微论方》首次将疳证归类为五疳。本草文献中对本病贡献最大的为明《本草纲目》。清《温病条辨》首次将本病治法作全面总结。１９９４年国家中医药管理局颁布的《中医病证诊断疗效标准》首次以法规的形式将本病作了统一规范     

Factors impacting on quality of life in Parkinson's disease: Results from an international survey

Current management guidelines for the treatment of patients with Parkinson's disease (PD) are limited due to the lack of knowledge of factors that influence health‐related quality of life (HRQL). To assess the HRQL of people with PD, and to systematically identify and evaluate those factors (other than disease severity and medication, which could have an impact), we undertook a cross‐sectional, randomized selection, multicenter international survey of patients with PD, caregivers, and clinicians. Face‐to‐face interviews were conducted with subjects in six countries. Disease severity, medication, and other factors hypothesized to influence HRQL were assessed using a combination of specially developed questionnaires and validated instruments including the Parkinson's Disease Questionnaire‐39 (HRQL), Hoehn and Yahr Stage (disease severity), and Beck's Depression Inventory (BDI; depression). Multiple linear regression models were used to demonstrate whether the factors investigated contribute significantly to HRQL. The results obtained indicated that Hoehn and Yahr stage and medication explained only 17.3% of the variability in HRQL of patients with PD, although both were significant (R² = 0.173, P < 0.05). Other factors increased the explanatory power to adjusted R² = 0.597, with BDI being the most significant predictor of variability in HRQL (adjusted R² = 0.582; P < 0.001), followed by “Satisfaction with the explanation of the condition at diagnosis” and “Current feelings of optimism” (both P < 0.05). These factors, in addition to disease severity and medication, explain 59.7% of the variability in HRQL across the population. In conclusion, depression (as measured by the BDI) in PD, “satisfaction with the explanation of the condition at diagnosis” and “current feelings of optimism” have a significant impact on HRQL. The completion of this initial analysis is the first step towards developing management guidelines that truly influence the HRQL of patients with PD. © 2001 Movement Disorder Society.     

血管紧张素转换酶基因多态性与冠心病关系的研究

目的：探讨血管紧张素转换酶（ACE）基因多态性与冠心病及冠状动脉病变支数的关系。方法：应用PCR扩增ACE基因的16内含子上的287bp插入／缺失片段，确定ACE基因型。在各组间进行基因型和等位基因频率的比较，采用多因素逐步logistic回归分析ACE的DD基因型及其他易患因素对冠心病的作用。用冠状动脉造影标准确诊冠心病。结果：（1）冠心病组ACE的DD基因型和D等位基因频率均高于对照组（x^2分别为16．04，16．08；P均＜0．01）。D等位基因与冠心病的关联性较高（隐性作用时OR＝2．15，P＜0．01，显性作用时OR＝2．84，P＜0．01）。（2）冠状动脉单支，双支，三支病变组之间，ACE基因型分布和D等位基因频率均一致（x^2分别为1．50，1．06，P均＞0．05）。（3）多因素逐步logistic回归分析，排除公认的冠心病危险因素后，ACE的DD基因型仍是冠心病的危险因素。结论：（1）ACE基因多态性与冠心病有相关性；（2）ACE基因型分布和D等位基因频率与冠状动脉病变支数无关；（3）ACE的DD基因型是冠心病的独立危险因素。     

无心肌梗死冠心病患者心功能变化与室性心律失常的关系

目的：探讨冠心病心力衰竭对各种室性心律失常的影响。方法：选择381例冠心病住院患者，根据心功能分级标准（NYHA）分为4组，检测24h动态心电图（Holter），分析室性心律失常类型及发生率，进行统计分析。结果：各级心功能组其室性心律失常发生率经x^2检验示，室性心律失常的发生率除联律和持续性或非持续性室性心动过速外各组间差异无显著性（P＞0．05）。结论：非心肌梗死冠心病患者室性心律失常发作频率与心力衰竭的程度无关，但联律和持续或非持续性室性心动过速在重度心力衰竭患者发生率增加。     

经皮冠状动脉腔内支架置入术治疗冠心病

目的:评估冠状动脉内支架置入术的效果。方法:回顾性分析1996年2月～2000年2月我院接受冠状动脉内支架置入术的120例病人的治疗效果。结果:在183处病变共置入支架125只。在未经介入性治疗的病变置入支架(De novo stenting)101只,PTCA结果不理想(suboptimal)置入支架19只,2例PTCA并发夹层,濒临闭塞时紧急置入支架(Bail-out stenting)2只,在再狭窄病变置入支架3只。置入支架平均直径3.00±0.69mm,平均长度18.15±10.26mm。手术即刻成功率98.4％,主要并发症率为1.6％((2例AMI)。结论:冠脉内支架置入术是治疗冠心病的一种安全有效的介入性治疗技术,其成功率高,并发症少。     

Comparison of Sputum and Serum Eosinophil Cationic Protein (ECP) Levels in Nonatopic Asthma and Chronic Obstructive Pulmonary Disease

The aim of the present study was to investigate whether sputum eosinophil cationic protein (ECP) concentrations could be a useful marker in the differential diagnosis between intrinsic asthma and chronic obstructive pulmonary disease (COPD). For this purpose total blood eosinophil counts were obtained and concentrations of serum and sputum ECP from 10 nonatopic asthmatics with a mild attack and 9 COPD patients with acute exacerbation were measured by radioimmunoassay. Mean serum ECP concentration was 54.3 ± 23.0 g/L in the asthmatic group and 83.3 ± 79.2 g/L in the COPD group (p: n.s.). In the group of asthmatics mean sputum ECP level was 984.5 ± 1245.5 mg/L/g sputum and in the COPD group it was 417.5 ± 363.5 mg/L/g sputum. There was no significant difference in sputum ECP levels between patients with asthma and COPD. We conclude that neither sputum nor serum ECP levels are useful markers in differential diagnosis of asthma attack and acute exacerbation of COPD.     

Utility of pulmonary function testing in the management of chronic obstructive pulmonary disease

This study sought to measure the effect of pulmonary function testing (PFT) data on the decisions made by generalist physicians in the management of chronic obstructive pulmonary disease (COPD). 148 physicians were randomly assigned to two groups, both of which were asked to manage two identical fictitious but representative cases of COPD, which included history, physical, x-ray, and laboratory results. The experimental group received PFT results in addition. No significant difference was noted between the two groups in management based on availability of PFT data. The optimum utility of PFT data in the management of COPD may be exaggerated and has yet to be determined. Received from the Department of Medicine, Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Presented at the Annual Scientific Meeting of the American College of Chest Physicians, October 28, 1992, Chicago, Illinois.